Literature DB >> 22552010

Lynch syndrome: new tales from the crypt.

C Richard Boland1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22552010      PMCID： PMC3805503          DOI： 10.1016/S1470-2045(12)70134-1

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  9 in total

Review 1.  Microsatellite instability in colorectal cancer.

Authors:  C Richard Boland; Ajay Goel
Journal:  Gastroenterology       Date:  2010-06       Impact factor: 22.682

2.  Rapid development of colorectal neoplasia in patients with Lynch syndrome.

Authors:  Daniel L Edelstein; Jennifer Axilbund; Melanie Baxter; Linda M Hylind; Katharine Romans; Constance A Griffin; Marcia Cruz-Correa; Francis M Giardiello
Journal:  Clin Gastroenterol Hepatol       Date:  2010-11-09       Impact factor: 11.382

3.  Microsatellite instability and DNA mismatch repair protein deficiency in Lynch syndrome colorectal polyps.

Authors:  Matthew B Yurgelun; Ajay Goel; Jason L Hornick; Ananda Sen; Danielle Kim Turgeon; Mack T Ruffin; Norman E Marcon; John A Baron; Robert S Bresalier; Sapna Syngal; Dean E Brenner; C Richard Boland; Elena M Stoffel
Journal:  Cancer Prev Res (Phila)       Date:  2012-01-18

Review 4.  Evolution of the nomenclature for the hereditary colorectal cancer syndromes.

Authors:  C Richard Boland
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

5.  HNPCC-associated small bowel cancer: clinical and molecular characteristics.

Authors:  Karsten Schulmann; Frank E Brasch; Erdmute Kunstmann; Christoph Engel; Constanze Pagenstecher; Holger Vogelsang; Stefan Krüger; Tilman Vogel; Hanns-Peter Knaebel; Josef Rüschoff; Stephan A Hahn; Magnus V Knebel-Doeberitz; Gabriela Moeslein; Stephen J Meltzer; Hans K Schackert; Christiane Tympner; Elisabeth Mangold; Wolff Schmiegel
Journal:  Gastroenterology       Date:  2005-03       Impact factor: 22.682

Review 6.  Mutations at coding repeat sequences in mismatch repair-deficient human cancers: toward a new concept of target genes for instability.

Authors:  Alex Duval; Richard Hamelin
Journal:  Cancer Res       Date:  2002-05-01       Impact factor: 12.701

7.  Prevalence of mismatch repair-deficient crypt foci in Lynch syndrome: a pathological study.

Authors:  Matthias Kloor; Cathrin Huth; Anita Y Voigt; Axel Benner; Peter Schirmacher; Magnus von Knebel Doeberitz; Hendrik Bläker
Journal:  Lancet Oncol       Date:  2012-05-01       Impact factor: 41.316

Review 8.  Aberrant crypt foci: what we know and what we need to know.

Authors:  Akshay K Gupta; Theresa P Pretlow; Robert E Schoen
Journal:  Clin Gastroenterol Hepatol       Date:  2007-04-12       Impact factor: 11.382

9.  Dendritic cell and macrophage infiltration in microsatellite-unstable and microsatellite-stable colorectal cancer.

Authors:  Kathrin Bauer; Sara Michel; Miriam Reuschenbach; Nina Nelius; Magnus von Knebel Doeberitz; Matthias Kloor
Journal:  Fam Cancer       Date:  2011-09       Impact factor: 2.375
  9 in total
  3 in total

1.  Mutation rates, spectra, and genome-wide distribution of spontaneous mutations in mismatch repair deficient yeast.

Authors:  Gregory I Lang; Lance Parsons; Alison E Gammie
Journal:  G3 (Bethesda)       Date:  2013-09-04       Impact factor: 3.154

Review 2.  How Should We Test for Lynch Syndrome? A Review of Current Guidelines and Future Strategies.

Authors:  Richard Gallon; Peter Gawthorpe; Rachel L Phelps; Christine Hayes; Gillian M Borthwick; Mauro Santibanez-Koref; Michael S Jackson; John Burn
Journal:  Cancers (Basel)       Date:  2021-01-22       Impact factor: 6.639

3.  Continuing difficulties in interpreting CNV data: lessons from a genome-wide CNV association study of Australian HNPCC/lynch syndrome patients.

Authors:  Bente A Talseth-Palmer; Elizabeth G Holliday; Tiffany-Jane Evans; Mark McEvoy; John Attia; Desma M Grice; Amy L Masson; Cliff Meldrum; Allan Spigelman; Rodney J Scott
Journal:  BMC Med Genomics       Date:  2013-03-26       Impact factor: 3.063
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.